Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Bratisl Lek Listy ; 118(8): 460-466, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29050483

RESUMO

OBJECTIVE: The effects of dimethyl phthalate, diethyl phthalate, diisobutyl phthalate, di-n-butyl phthalate, benzylbutyl phthalate, di-2-ethylhexyl phthalate were investigated on human prostate cancer cell lines DU145 and PC3 in vitro. MATERIALS AND METHODS: Standards of dimethyl phthalate, diethyl phthalate, di-isobutyl phthalate, dibutyl phthalate, benzyl butyl phthalate, and di-ethyl hexyl phthalate were used. Alpha lipoic acid was used as antioxidant compound. DU145 and PC3 human prostate carcinoma cells were used. MTT assay were used for cytotoxicity assay. RESULTS: A low dose proliferative effect of phthalates in vitro was observed. With the hypothesis of the inhibition of aerobic glycolysis activity in cancer treatment, α-lipoic acid was applied to cells; where as a contrary to previous studies, no change in the cell proliferation was observed. In combination with ALA, at IC50 and lower doses, an increase of the cytotoxic effect was found for DIBP, DBP and BBP; while for DMP, DEP and DEHP, a decrease was observed for DU145 cells. In PC3 cells, a decrease was observed for DMP, DEP and DBPs; while no significant difference were observed for DEHP, DIBP and BBP. CONCLUSSION: The present study demonstrates preliminary information regarding the low dose proliferative effects of phthalates in prostate cancer in vitro (Tab. 2, Fig. 2, Ref. 65).


Assuntos
Adenocarcinoma , Morte Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Ácidos Ftálicos/farmacologia , Neoplasias da Próstata , Ácido Tióctico/farmacologia , Linhagem Celular Tumoral , Dibutilftalato/análogos & derivados , Dibutilftalato/farmacologia , Dietilexilftalato/farmacologia , Humanos , Masculino
2.
J Cell Biol ; 94(2): 335-40, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6809769

RESUMO

This paper examines, in mouse spleen lymphocytes, the effect of anti-immunoglobulin (anti-Ig) on the cytoplasmic free calcium concentration, [Ca2+]i, measured with the fluorescent indicator quin2, and the relationship of [Ca2+]i to the capping of surface Ig. Anti-Ig causes a rapid rise of [Ca2+], which precedes capping. Assuming that only those 40-50% of the cells which can bind anti-Ig (the B cells) undergo a [Ca2+]i response, [Ca2+]i in those cells approaches 500 nM. It declines to resting levels over many minutes, roughly paralleling the formation of caps. Part of the [Ca2+]i signal is due to stimulated influx across the plasma membrane, since in Ca2+-free medium, anti-Ig gives a smaller and shorter [Ca2+]i rise. The amplitude of this reduced transient now varies inversely with quin2 content, as if some 0.25 mmol Ca per liter of cells was released into the cytoplasm from internal stores. These stores are probably sequestered in organelles since A23187 in Ca2+-free medium also causes a transient [Ca2+]i rise after which anti-Ig has no effect. These organelles seem not to be mitochondria because uncouplers have hardly any effect on [Ca2+]i. Though anti-Ig normally raises [Ca2+]i before causing capping, there seems to be no causal link between the two events. Cells in Ca2+-free medium whose stores have been emptied by A23187, still cap with anti-Ig even though there is no [Ca2+]i rise. Cells loaded with quin2 in the absence of external Ca2+ still cap anti-Ig normally even though their [Ca2+]i remains steady at below 30 nM, four times lower than normal resting [Ca2+]i.


Assuntos
Linfócitos B/imunologia , Cálcio/fisiologia , Capeamento Imunológico , Trifosfato de Adenosina/fisiologia , Animais , Anticorpos Anti-Idiotípicos , Calcimicina/farmacologia , Citoplasma/fisiologia , Corantes Fluorescentes , Camundongos , Mitocôndrias/efeitos dos fármacos , Quinolinas , Receptores de Antígenos de Linfócitos B/imunologia , Baço
3.
Eur J Clin Nutr ; 61(2): 212-20, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16969381

RESUMO

OBJECTIVE: Frequent consumption of nuts is associated with favorable plasma lipid profiles and reduced risk of coronary heart disease (CHD). This study was conducted to investigate the effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men compared with baseline and control diet, and also to measure the anthropometric parameters, habitual physical activities, nutrient intake and endothelial function. SUBJECTS AND DESIGN: Fifteen hypercholesterolemic men aged 48+/-8 years were recruited voluntarily. A well-controlled, 2-period (P1 and P2) study design with a total of 8-week was implemented. In the P1, subjects consumed a control diet (low-fat, low-cholesterol and high-carbohydrate). During the P2, the control diet was supplemented with MUFA-rich hazelnut (40 g/day), which provided 11.6% of total energy content. Anthropometric parameters and habitual physical activities were recorded. Plasma total and HDL cholesterol, TAG, ApoA-1, Apo B, total homocysteine and glucose concentrations were measured. All parameters and measurements were obtained at baseline and end of each 4-week diet period. RESULTS: Body weights of subjects remained stable throughout the study. Compared with baseline, the hazelnut-enriched diet decreased (P<0.05) the concentrations of VLDL cholesterol, triacylglycerol, apolipoprotein B by 29.5, 31.8, and 9.2%, respectively, while increasing HDL cholesterol concentrations by 12.6%. Total/HDL cholesterol and LDL/HDL cholesterol ratios favorably decreased (P<0.05). Although insignificant there was a decreasing trend for the rest of parameters, particularly in total (5.2%) and LDL cholesterol (3.3%) in subjects consuming a hazelnut-enriched diet compared to that of the baseline. No changes were found in fasting levels of glucose, Apo A-1 and homocysteine between the control and hazelnut-enriched diets. CONCLUSIONS: This study demonstrated that a high-fat and high-MUFA-rich hazelnut diet was superior to a low-fat control diet because of favorable changes in plasma lipid profiles of hypercholesterolemic adult men and, thereby positively affecting the CHD risk profile. SPONSORSHIP: Funding provided by a grant from the Hazelnut Promotion Group, Giresun, Turkey.


Assuntos
Colesterol/sangue , Corylus , Gorduras Insaturadas na Dieta/administração & dosagem , Hipercolesterolemia/sangue , Hipercolesterolemia/dietoterapia , Antropometria , Apolipoproteínas B/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , VLDL-Colesterol/sangue , Estudos Cross-Over , Gorduras na Dieta/administração & dosagem , Gorduras na Dieta/metabolismo , Gorduras Insaturadas na Dieta/metabolismo , Células Endoteliais/fisiologia , Exercício Físico/fisiologia , Homocisteína/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Triglicerídeos/sangue
4.
Biochim Biophys Acta ; 931(1): 10-5, 1987 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-2820507

RESUMO

Two steps are involved in the uptake of Cr(VI): (1) the diffusion of the anion CrO4(2-) through a facilitated transport system, presumably the non-specific anion carrier and (2) the intracellular reduction of Cr(VI) to Cr(III). The intracellular reduction of Cr(VI), keeping the cytoplasmic concentration of Cr(VI) low, facilitates accumulation of chromate from extracellular medium into the cell. In the present paper, a direct demonstration of intracellular chromium reduction is provided by means of electron paramagnetic (spin) resonance (EPR) spectroscopy. Incubation of metabolically active rat thymocytes with chromate originates a signal which can be attributed to a paramagnetic species of chromium, Cr(V) or Cr(III). The EPR signal is originated by intracellular reduction of chromium since: (1) it is observed only when cells are incubated with chromate, (2) it is present even after extensive washings of the cells in a chromium-free medium; (3) it is abolished when cells are incubated with drugs able to reduce the glutathione pool, i.e., diethylmaleate or phorone; and (4) it is abolished when cells are incubated in the presence of a specific inhibitor of the anion carrier, 4-acetamido-4'-isothiocyanatostilbene-2-2'-disulfonic acid.


Assuntos
Cromo/metabolismo , Timo/metabolismo , Animais , Membrana Celular/metabolismo , Cromatos/metabolismo , Espectroscopia de Ressonância de Spin Eletrônica , Líquido Intracelular/metabolismo , Cetonas/farmacologia , Maleatos/farmacologia , Oxirredução , Ratos , Ratos Endogâmicos , Timo/efeitos dos fármacos
5.
Biochim Biophys Acta ; 599(1): 110-7, 1980 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-7397141

RESUMO

Dipalmitoyl phosphatidylcholine vesicles incubated in the presence of increasing amounts of myristic acid showed a progressive translocation of phospholipid molecules across a dialysis membrane. The rate of phospholipid translocation increased abruptly at a 'critical' value of myristic acid concentrations. The translocation rate of mixed dipalmitoyl phosphatidylcholine/myristic acid vesicles obtained by cosonicating the two components was also dependent on a 'critical' fatty acid concentration. A marked release of K+ and different responses of fluorescent probes to the fatty acid addition were observed at this concentration.


Assuntos
Ácidos Graxos/farmacologia , Bicamadas Lipídicas/metabolismo , Fosfatidilcolinas/metabolismo , Fosfolipídeos/metabolismo , Cromatografia em Gel , Diálise , Cinética , Potássio/metabolismo
6.
Biochim Biophys Acta ; 599(1): 118-26, 1980 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-7397142

RESUMO

Size enlargement of dipalmitoyl phosphatidylcholine vesicles was greatly accelerated in the range of the phase-transition temperatures, when fatty acid concentration was above a threshold level ('critical' concentration). This 'critical' concentration varied with the length of the fatty acid chain. The size enlargement process had second-order kinetics dependent on the vesicle concentration. Alkaline pH and low ionic strength inhibited the rate of size enlargement. Phospholipid exchange between dimyristoyl and dipalmitoyl phosphatidyl-choline vesicles increased abruptly above a 'critical' fatty acid concentration. The donor vesicles were those vesicles in which fatty acids reached the 'critical' concentration. The phospholipid exchange occurred both in fluid- and in solidstate vesicles. The 'critical' fatty acid concentration accelerating the phospholipid exchange process was lower than that accelerating the size enlargement process. The phospholipid exchange process explained in terms of a diminished hydrophobic attraction among the phospholipid molecules of the bilayer occurs via a free phospholipid molecule transfer through the aqueous phase. The size enlargement process is interpreted in terms of high fatty acid concentration in the membrane fluid domains. The membrane structure is locally perturbed inducing vesicle sticking after collision.


Assuntos
Ácidos Graxos/metabolismo , Bicamadas Lipídicas/metabolismo , Fosfolipídeos/metabolismo , Cinética , Temperatura
7.
Biochim Biophys Acta ; 643(1): 177-81, 1981 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-6165389

RESUMO

The effect of valinomycin, nigericin and gramicidin on the cellular O2 consumption and on ATP content has been investigation. It has been found that while valinomycin and nigericin interfere with mitochondrial functions, gramicidin D does not show any appreciable effect. These results are explained in terms of the differing abilities of ionophores to redistribute among intracellular membranes.


Assuntos
Ionóforos/farmacologia , Linfócitos/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Gramicidina/farmacologia , Linfócitos/efeitos dos fármacos , Masculino , Mitocôndrias/efeitos dos fármacos , Nigericina/farmacologia , Consumo de Oxigênio/efeitos dos fármacos , Ratos , Rotenona/farmacologia , Valinomicina/farmacologia
8.
Biochim Biophys Acta ; 501(2): 317-29, 1978 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-23158

RESUMO

The aerobic uptake of inorganic ions, such as 86Rb+ or 125I-, by submitochondrial particles, is about one order of magnitude lower than the uptake of organic ions, such as acridines or 8-anilino-1-naphthalene sulphonate. The values of deltapH, the transmembrane pH differential, and deltapsi, the transmembrane membrane potential are between 60 and 100 mV when calculated on the inorganic ions and between 150 and 240 mV when calculated on the organic ions. The discrepancy between the deltapH and deltapsi values from organic and inorganic ions is large at high but not at low ion/protein ratios. 2. In the absence of weak bases and strong acids the values of deltamuH, the proton electrochemical potential difference, are close to 100 mV and the magnitude of deltapH and deltapsi are similar. Weak bases decrease deltapH and enhance deltapsi. Strong acids decrease deltapsi and enhance deltapH. Interchangeability of deltapH with deltapsi occurs at low concentrations of weak bases and strong acids. High concentrations of weak bases and strong acids cause depression of deltamuH. 3. Concentrations of weak bases capable of abolishing deltapH, do not affect ATP synthesis. Concentrations of strong acids capable of abolishing deltapsi affect only slightly ATP synthesis. Concentrations of weak bases and strong acids capable of causing a decline of deltapH + deltapsi inhibit ATP synthesis. 4. Depression of deltamuH is paralleled by inhibition of ATP synthesis and decline of deltaGp, the phosphate potential. Abolition of ATP synthesis occurs only when deltamuH is below 20 mV. The deltaGp/deltamuH ratio increases hyperbolically with the decrease of deltamuH.


Assuntos
Mitocôndrias Cardíacas/fisiologia , Fosfatos/metabolismo , Acridinas/metabolismo , Trifosfato de Adenosina/biossíntese , Naftalenossulfonato de Anilina/metabolismo , Animais , Bovinos , Transporte de Elétrons/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Iodo/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Prótons , Rubídio/metabolismo
9.
J Leukoc Biol ; 69(3): 482-9, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11261797

RESUMO

Macrophage-muscle cell interactions are complex, and the majority is unknown. The persistence of inflammatory cells in skeletal muscle could be critical for myofiber viability. In the present paper, we show that FasL plays a role in the resolution of muscle inflammation. We analyzed inflamed muscles of normal mice treated from day 3 to day 8 with a FasL inhibitor (Fas-Ig) or with control Ig. Treated muscles were collected at 3, 5, and 10 days. The treatment with recombinant Fas-Ig protein induced a severe persistence of inflammatory cells at 5 days (115,000+/-27,838 vs. 41,661+/-6848, p<0.01) and 10 days from injury (145,500+/-40,850 vs. 5000+/-1000, p<0.001). Myofiber regeneration was highly impaired (37+/-14 vs. 252+/-28, p<0.01). Apoptosis of phagocytic cells was absent during Fas-Ig treatment (0.9+/-0.6 vs. 1300+/-150, p<0.0001), but apoptotic, mononucleated cells appeared at day 10, 2 days after the suspension of Fas-Ig administration. The time course of FasL expression during muscle inflammation, at mRNA and protein level, reveals a peak during myoblast proliferation. The peak of FasL expression coincides with the peak of apoptosis of phagocytic cells. In situ hybridization shows the co-expression of FasL and MyoD mRNA in mononucleated cells, i.e., myoblasts. Experiments on the myoblast cell culture confirmed the expression of FasL in myoblasts. The findings shown here indicate one of the pathways to control myoblast-macrophage interaction and might be relevant for the control of inflammatory cells in muscle tissue. Perhaps altering FasL expression with recombinant proteins could ameliorate inflammation in degenerative myopathies and up-regulate muscle regeneration.


Assuntos
Macrófagos/citologia , Glicoproteínas de Membrana/antagonistas & inibidores , Fibras Musculares Esqueléticas/fisiologia , Músculo Esquelético/fisiologia , Regeneração/fisiologia , Animais , Apoptose/fisiologia , Comunicação Celular/fisiologia , Sobrevivência Celular/fisiologia , Técnicas de Cocultura , Proteína Ligante Fas , Imunoglobulinas/imunologia , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/imunologia , Glicoproteínas de Membrana/fisiologia , Camundongos , Fibras Musculares Esqueléticas/citologia , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/metabolismo , Miosite/induzido quimicamente , Miosite/patologia , Receptor fas/fisiologia
10.
Curr Cancer Drug Targets ; 3(6): 427-32, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14683500

RESUMO

Angiogenesis is crucial for tumor development and progression, and antiangiogenetic therapy represents a promising approach for cancer treatment. Thus, the in-depth understanding of the molecular mechanism(s) regulating angiogenesis, together with the characterization of molecules expressed by endothelial cells and involved in distinct steps of the angiogenetic process, will greatly improve the design of new and more effective therapeutic strategies in human malignancies. Endoglin (CD105), a cell membrane glycoprotein predominantly expressed on cellular lineages within the vascular system, and over-expressed on proliferating endothelial cells, is involved in blood vessels development and represents a powerful marker of neovascularization. CD105 binds several factors of the Transforming Growth Factor (TGF)-beta superfamily, a pleiotropic cytokine that regulates different cellular functions including proliferation, differentiation and migration. In human malignancies of different histotype, CD105 is highly expressed on endothelial cells of both peri- and intra-tumoral blood vessels, while it is weakly expressed or absent on neoplastic cells. This unique tissue distribution strongly suggests for a prognostic, diagnostic and therapeutic potential of CD105 in neoplastic diseases. In this review we will summarize the structural and functional features of CD105, as well as its tissue distribution in normal and neoplastic tissues. Furthermore, the practical implications of CD105 in human malignancies will also be discussed.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias/irrigação sanguínea , Neovascularização Patológica/metabolismo , Molécula 1 de Adesão de Célula Vascular/metabolismo , Animais , Antígenos CD , Endoglina , Humanos , Receptores de Superfície Celular
11.
J Neuropathol Exp Neurol ; 56(1): 45-57, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8990128

RESUMO

Apoptosis plays a major role in several diseases, including viral infections, autoimmune diseases, cancer, cardiac infarct, and neurological disorders. To investigate the role of apoptosis in muscular dystrophy, dystrophin-deficient (mdx) mice were subjected to spontaneous exercise and skeletal muscles were analyzed for apoptosis and ubiquitin. The increase of apoptotic myonuclei after exercise was detected by TUNEL, by electron microscopy, and by DNA analyses for high molecular weight and for ladder fragments. Expression of ubiquitin correlated with exercise and with positive myonuclei for apoptosis. Biochemical analysis confirmed a high level of ubiquitination both in sarcoplasmic and myofibrillar proteins. Muscles from sedentary congenit control mice (C57B ) were negative for apoptosis, while after exercise some nuclei were positive. We also revealed that normal myoblasts committed to apoptosis in vitro showed an increased expression of ubiquitin. Western blot for bcl-2, FasL, and BAG1 showed a significant decrease of bcl-2 product only in mdx mice after exercise. Thus, spontaneous exercise results in the increase of ubiquitin expression and in the reduction of bcl-2 tightly related to programmed cell death in mdx mice. These findings confirm that DNA fragmentation, absent in muscles of sedentary normal mice but present in mdx mice at rest, dramatically increases after exercise, shedding new light on exercise-induced muscle damage and on its progression in dystrophinopathies.


Assuntos
Apoptose , Distrofina/deficiência , Proteínas de Membrana , Músculo Esquelético/patologia , Distrofia Muscular Animal/patologia , Esforço Físico , Ubiquitinas/metabolismo , Animais , Apoptose/genética , Núcleo Celular/metabolismo , Núcleo Celular/ultraestrutura , Células Cultivadas , Fragmentação do DNA , Proteínas de Ligação a DNA , Proteína Ligante Fas , Glicoproteínas de Membrana/análise , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos mdx , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Distrofia Muscular Animal/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/análise , Corrida , Fatores de Transcrição/análise
12.
FEBS Lett ; 373(3): 291-5, 1995 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-7589485

RESUMO

The current view indicates that after eccentric exercise myofibers are mechanically damaged and therefore an inflammatory and necrotic process occurs. In the present paper we examine the possibility that apoptosis plays a role in normal and dystrophin-deficient muscles after running. We analysed for apoptosis normal and dystrophin-deficient mouse muscles after a night of spontaneous wheel-running followed by two days of rest. Terminal deoxynucleotidyl transferase-mediated end-labeling of DNA in nuclei in tissue sections and gel electrophoresis of extracted DNA showed the presence of fragmented DNA. Furthermore, ubiquitin, a protein whose appearance is related to apoptosis, increased in muscles of both dystrophic and normal runner mice. The present findings which confirm that DNA damage is absent in muscles of sedentary mice but present in muscles of runner mice offer a new hypothesis on early events of muscle damage.


Assuntos
Apoptose , Dano ao DNA , Fibras Musculares Esqueléticas/metabolismo , Distrofia Muscular Animal/fisiopatologia , Esforço Físico/fisiologia , Ubiquitinas/genética , Animais , Western Blotting , Núcleo Celular/genética , Núcleo Celular/metabolismo , DNA/análise , DNA/metabolismo , DNA Nucleotidilexotransferase/metabolismo , Dexametasona/farmacologia , Distrofina/deficiência , Distrofina/genética , Eletroforese em Gel de Ágar , Expressão Gênica/genética , Hibridização In Situ , Camundongos , Camundongos Endogâmicos mdx , Fibras Musculares Esqueléticas/citologia , Distrofia Muscular Animal/genética , Distrofia Muscular Animal/patologia , Miofibrilas/genética , Miofibrilas/metabolismo , Ubiquitinas/metabolismo
13.
Curr Drug Targets ; 4(4): 291-6, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12699349

RESUMO

Targeting of tumor vasculature is a promising strategy for cancer treatment. Among endothelial cell markers, Endoglin, a cell membrane glycoprotein, is emerging as an attractive therapeutic target on angiogenetic blood vessels, and it currently represents a powerful marker to quantify tumor angiogenesis. In normal human tissues, Endoglin is weakly expressed on erytroid precursors, stromal cells and activated monocytes, whereas it is strongly expressed on proliferating endothelial cells. In human neoplasias of different histotype, Endoglin is mainly present on endothelial cells of both peri- and intra-tumoral blood vessels, while it is weakly expressed or absent on neoplastic cells. Endoglin is an accessory component of the receptor complex of Transforming Growth Factor (TGF)-beta, a pleiotropic cytokine that modulates angiogenesis by the regulation of different cellular functions including proliferation, differentiation and migration. Interestingly, the over-expression of Endoglin antagonizes several cellular responses to TGF-beta1, while its down-regulation potentiates cellular responses to TGF-beta1. In animal models, administration of radiolabeled anti-Endoglin monoclonal antibodies (mAb) efficiently images primary tumors, and naked or conjugated anti-Endoglin mAb suppress angiogenesis and tumor growth. In this review we will summarize the complex of experimental evidences pointing to Endoglin as a vascular target to design innovative bioimmunotherapeutic strategies in human neoplasias.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Neoplasias/tratamento farmacológico , Molécula 1 de Adesão de Célula Vascular/fisiologia , Animais , Antígenos CD , Biomarcadores Tumorais , Endoglina , Humanos , Neoplasias/patologia , Prognóstico , Receptores de Superfície Celular , Fator de Crescimento Transformador beta/farmacologia , Molécula 1 de Adesão de Célula Vascular/química , Molécula 1 de Adesão de Célula Vascular/genética
14.
Cancer Chemother Pharmacol ; 30(3): 221-5, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1628371

RESUMO

Tumor-tissue platinum levels and major pharmacokinetic parameters were determined in 11 patients with head and neck squamous cancer (HNSC) who were given cisplatin (50 mg/m2 daily x 2 days) and 5-fluorouracil (5-FU; 1000 mg/m2, continuous infusion x 5 days) either i.a. or i.v. The plasma peak platinum concentrations (cmax) and the areas under the curve for total platinum concentration versus time (AUC) during i.a. infusions were lower than the i.v. cmax (mean, 1.92 +/- 0.28 and 4.08 +/- 2.80 mg/l, for i.a. and i.v. infusions, respectively) and AUC values (mean, 22.55 +/- 4.96 and 40.66 +/- 10.71 mg h-1 l-1 for i.a. and i.v. treatment, respectively), suggesting a first-passage extraction of the drug by the tumor mass during i.a. infusion. However, no statistically significant difference was found in platinum tumor concentrations after i.a. administration versus i.v. infusion. The lack of a difference in tumor platinum concentrations between the i.a. and the i.v. administration routes might be explained either by a relatively high blood supply to the tumor area, enabling efflux of the surplus free platinum from the tissue, or by the delay between drug infusion and biopsy. After three cycles of i.a. treatment good tumor remission was obtained with minimal local toxicity. Larger clinical studies testing the advantages of the i.a. administration route over i.v. infusion appear to be necessary.


Assuntos
Carcinoma de Células Escamosas/metabolismo , Cisplatino/farmacocinética , Neoplasias de Cabeça e Pescoço/metabolismo , Adulto , Idoso , Carcinoma de Células Escamosas/tratamento farmacológico , Cisplatino/administração & dosagem , Feminino , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Humanos , Infusões Intra-Arteriais , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade
15.
Neurosci Lett ; 252(2): 123-6, 1998 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-9756337

RESUMO

Apoptosis has been demonstrated to occur in differentiated myocardial muscle, neonatal skeletal muscle and skeletal myoblasts in response to injury. In this report, we studied differentiated normal and dystrophin deficient murine skeletal muscle cell cultures that have been injured by a pulse of cis-platinum (2 h). Forty-eight hours after DNA damage, dystrophin positive myotubes appeared almost normal though some myoblasts showed DNA fragmentation. On the other hand, dystrophin deficient myotubes presented progressive degeneration via apoptosis detected either by TUNEL or by nuclear morphology. Degeneration of mdx muscle fibers was confirmed by counting both the number of myotubes observed by contrast phase microscopy and myonuclei viewed by immunoreaction for MyoD. A 6-fold decrease in the number of muscle cells was observed in the dystrophin-deficient cell culture compared to the parental culture (P < 0.001). Direct evidence of degenerating myotubes displaying MyoD- and TUNEL-positive nuclei was obtained. Like myoblasts, differentiated dystrophin deficient myotubes were able to degenerate via apoptosis, showing that mature dystrophin deficient cells are fragile and undergo apoptosis when subjected to a mild injury which would normally be repaired in parental cells.


Assuntos
Apoptose/fisiologia , Dano ao DNA/fisiologia , Distrofina/deficiência , Fibras Musculares Esqueléticas/citologia , Fibras Musculares Esqueléticas/metabolismo , Animais , Animais Recém-Nascidos , Células Cultivadas , Distrofina/análise , Marcação In Situ das Extremidades Cortadas , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos mdx , Fibras Musculares Esqueléticas/química , Proteína MyoD/análise , Proteína MyoD/metabolismo
16.
Life Sci ; 44(26): 2097-104, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2747417

RESUMO

The biological effects of three furocoumarins on the proliferation of human normal peripheral blood lymphocytes have been investigated. Mitogen-stimulated human lymphocytes were assayed "in vitro" by measuring 3H-thymidine (3H-TdR) incorporation in the presence and in the absence of 15-30 microM 3-carbethoxypsoralen (3-CPs), trimethylangelicin (TMA) and psoralen (PSR) with and without UV-A irradiation (365 nm). The three furocoumarins differ in their ability to form mono- and bi-functional adducts with DNA pyrimidine bases and in producing reactive species of oxygen. At low furocoumarin doses and short times of UV-A irradiation (15-30 sec) used in the present study, 3-CPs did not affect 3H-TdR incorporation in PHA-stimulated human lymphocytes, TMA strongly inhibited 3H-TdR incorporation, while, unexpectedly, PSR increased 3H-TdR incorporation in the absence of irradiation, likely acting, under these experimental conditions, as a co-mitogen.


Assuntos
Furocumarinas/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Ficusina/farmacologia , Humanos , Técnicas In Vitro , Ativação Linfocitária/efeitos da radiação , Linfócitos/efeitos da radiação , Terapia PUVA , Acetato de Tetradecanoilforbol/farmacologia , Raios Ultravioleta
17.
Chem Phys Lipids ; 25(1): 93-9, 1979 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-498381

RESUMO

A method for labelling the polar head groups of cardiolipin is described. Labelling was carried out on sonicated cardiolipin/water suspensions. The free hydroxyl group of cardiolipin was oxidised with an excess of p-(diazonium) benzenesulfonic acid (DABS) and then reduced with NaB3H4. Isopropanol was oxidised in the presence of DABS to test the reactivity of the diazonium salts, and the reaction product was analysed by means of gas-chromatography. Labelled cardiolipin, identified by thin-layer chromatography (TLC), was chromatographically pure and identical to untreated cardiolipin. The hydrolysis of cardiolipin confirmed that the labelling was at the level of polar head groups.


Assuntos
Cardiolipinas/análise , Cromatografia em Camada Fina , Marcação por Isótopo/métodos , Trítio
18.
Chem Biol Interact ; 53(3): 273-81, 1985 May.
Artigo em Inglês | MEDLINE | ID: mdl-3874001

RESUMO

The cytotoxic effects of chromium compounds in two oxidation states have been studied in rat thymocytes. endogenous nucleotide levels and oxygen consumption were examined as relevant parameters of the physiological state of the cell. Incubation of rat thymocytes with Cr(VI) produced a marked unbalance of endogenous purine nucleotide pool and a parallel decrease in oxygen consumption. A close correlation between the reduction of oxygen consumption and ATP level in rat thymocytes treated with increasing concentrations of Cr(VI) has been found. In rat thymocytes permeabilized with digitonin and in isolated rat liver mitochondria both Cr(VI) and Cr(III) showed, at different range of concentrations, a marked inhibition of maximal oxygen consumption rate (uncoupled respiration). The effects observed were depending on chromium oxidation state and on different mitochondrial sites of substrate oxidation.


Assuntos
Cromo/toxicidade , Linfócitos T/efeitos dos fármacos , Difosfato de Adenosina/farmacologia , Animais , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/farmacologia , Digitonina/farmacologia , Metabolismo Energético/efeitos dos fármacos , Técnicas In Vitro , Mitocôndrias/metabolismo , Oxirredução , Fosforilação Oxidativa/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Ratos , Linfócitos T/metabolismo
19.
Adv Exp Med Biol ; 141: 481-9, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-7090923

RESUMO

The effect of valinomycin, nigericin, gramicidin S and D, A23187 and X537A on respiration and cellular ATP content of rat spleen lymphocytes is presented. It has been found that while valinomycin and nigericin interfere with mitochondrial functions gramicidin D does not show an appreciable effect. These results are explained in terms of different ability of ionophores to re-distribute among intracellular membranes. A23187 and X537A, added with Ca2+, strongly enhanced O2 consumption and reduced cellular ATP content.


Assuntos
Ionóforos/farmacologia , Linfócitos/efeitos dos fármacos , Animais , Cátions Bivalentes , Cátions Monovalentes , Metabolismo Energético/efeitos dos fármacos , Linfócitos/metabolismo , Consumo de Oxigênio/efeitos dos fármacos , Ratos
20.
Minerva Gastroenterol Dietol ; 37(3): 163-7, 1991.
Artigo em Italiano | MEDLINE | ID: mdl-1665079

RESUMO

To contribute to a better understanding of the role of leukotrienes in inflammatory conditions of the upper gastrointestinal tract, leukotriene B4 (LTB4) levels were measured by specific radioimmunoassay in extracts of mucosal biopsies from the stomach and duodenum of control subjects and of patients with gastritis, benign gastric ulcer and duodenal ulcer. The control mucosa contained measurable levels of LTB4. Levels were 20% higher in gastritis than in controls and the lowest levels were found in the patients with no bile reflux. LTB4 levels were more than 3 times higher in duodenal ulcer (p less than 0.025) than in controls, whereas gastric ulcer margins had very low levels. No clear relationship was found between LTB4 levels and the drugs used in treatment. While these data do not explain the role of LTB4, they suggest that LTB4 may be an important mediator of the inflammation accompanying or leading to development of duodenal ulcer.


Assuntos
Mucosa Gástrica/química , Gastrite/metabolismo , Leucotrieno B4/análise , Úlcera Péptica/metabolismo , Análise de Variância , Biópsia , Úlcera Duodenal/metabolismo , Duodeno/química , Endoscopia , Humanos , Mucosa Intestinal/química , Radioimunoensaio , Úlcera Gástrica/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA